Corporate Accountability

RELEASE: Supreme Court Upholds Important Tool For Courts to Enforce Securities Laws

WASHINGTON – On news that the U.S. Supreme Circuit issued its decision in Liu v. SEC, holding that “a disgorgement award that does not exceed a wrongdoer’s net profits and is awarded for victims is” permissible equitable relief, CAC President Elizabeth Wydra issued the following statement:

Today’s ruling that federal courts may impose disgorgement awards in cases involving violations of the nation’s securities laws, requiring ill-gotten gains to be distributed from perpetrators to victims, is an important victory. 

As we argued on behalf of Members of Congress, the courts of appeals have unanimously held for over fifty years that disgorgement falls within the general equity powers that Congress gave district courts when they hear cases involving violations of the nation’s securities laws. In fact, Congress has premised key provisions of law in this area on the existence of disgorgement authority. The Supreme Court was right not to disturb Congress’s legislative plan that disgorgement be available to help enforce the nation’s securities laws.

#

Resources:

CAC brief on behalf of Members of Congress in Liu v. SEC: https://www.theusconstitution.org/litigation/liu-v-sec/ 

##

Constitutional Accountability Center is a think tank, public interest law firm, and action center dedicated to fulfilling the progressive promise of the Constitution’s text and history. Visit CAC’s website at www.theusconstitution.org.

###

More from Corporate Accountability

Corporate Accountability
U.S. Court of Appeals for the Third Circuit

Novartis v. Secretary United States Department of Health and Human Services

In Novartis v. Secretary United States Department of Health and Human Services, the United States Court of Appeals for the Third Circuit is considering whether the Inflation Reduction Act’s Medicare drug price negotiation program is...
Corporate Accountability
January 28, 2025

Federal Deposit Insurance as Jarkesy Waiver

Yale Journal on Regulation
An argument lurking just beneath the surface in a pending Fifth Circuit case could stem...
Corporate Accountability
U.S. Court of Appeals for the Second Circuit

Boehringer Ingelheim v. Department of Health and Human Services

In Boehringer Ingelheim v. Department of Health and Human Services, the United States Court of Appeals for the Second Circuit is considering whether the Inflation Reduction Act’s Medicare drug price negotiation program is an unconstitutional...
Corporate Accountability
U.S. Court of Appeals for the Fifth Circuit

Ortega v. Office of the Comptroller of the Currency

In Ortega v. Office of the Comptroller of the Currency, the United States Court of Appeals for the Fifth Circuit is considering a challenge to the Office of the Comptroller of the Currency’s authority to...
Corporate Accountability
U.S. Court of Appeals for the Fifth Circuit

Burgess v. Whang

In Burgess v. Whang, the Fifth Circuit is considering a challenge to the Federal Deposit Insurance Corporation’s authority to issue penalties and other supervisory orders. 
Corporate Accountability
October 23, 2024

The Constitution Doesn’t Entitle Drug Manufacturers to a Sweetheart Deal

Washington
Big Pharma is in federal appeals court making the absurd argument that Medicare shouldn’t be...
By: Nina Henry